Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer

Published: May 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics, today announced that Dr. Eric Hedrick has joined the company as Chief Medical Officer.

Back to news